The Role of 5-HT1a and 5-HT2a Receptors in Attention and Motor Control: a Mechanistic Study in Healthy Volunteers

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2006 Nov 25

PMID 17124621

Citations 17

Authors

Marleen Wingen

Kim P C Kuypers

Johannes G Ramaekers

Affiliations

Soon will be listed here.

Abstract

Rationale: Various studies have demonstrated a modulating role for serotonin in attention. Selective serotonin inhibitors have repeatedly been shown to impair performance in sustained attention tasks.

Objectives: To assess the contribution of serotonin reuptake inhibition and specific blockade of the pre-synaptic 5-HT(1a) receptor and the 5-HT(2a) receptor to deficits in attention.

Materials And Methods: The study was conducted according to a randomized, double-blind, placebo controlled, four-way crossover design including 16 healthy volunteers. Treatments consisted of oral administration of the selective serotonin reuptake inhibitor (SSRI) escitalopram 20 mg + placebo; escitalopram 20 mg + ketanserin (5-HT(2a) antagonist), 50 mg; escitalopram 20 mg + pindolol (5-HT(1a) antagonist) 10 mg; and placebo + placebo on four separate days. A range of performance tasks were conducted to assess the subjects' attention and motor functions.

Results: Escitalopram administered alone impaired tracking performance in a divided attention task. The combination of escitalopram and pindolol and escitalopram and ketanserin impaired divided attention as compared to placebo. In addition, escitalopram and ketanserin impaired sustained attention. Divided attention impairment observed after combined treatments did not significantly differ from impairments after escitalopram alone. Sustained attention impairment observed after combined escitalopram and ketanserin significantly differed from escitalopram alone.

Conclusions: 5HT(1a) blockade hardly affected SSRI effects on attention. Additional 5HT(2a) blockade, however, produced impairments of sustained attention and motor impulse control.

Citing Articles

Serotonergic and Adrenergic Neuroreceptor Manipulation Ameliorates Core Symptoms of ADHD through Modulating Dopaminergic Receptors in Spontaneously Hypertensive Rats.

Madhyastha S, Rao M, Renno W Int J Mol Sci. 2024; 25(4).

PMID: 38396978 PMC: 10888658. DOI: 10.3390/ijms25042300.

Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [11C]AZ10419369 Positron Emission Tomography Study.

Tangen A, Veldman E, Svensson J, Tiger M, Nord M, Sorjonen K Int J Neuropsychopharmacol. 2022; 26(4):241-248.

PMID: 36573320 PMC: 10109060. DOI: 10.1093/ijnp/pyac084.

Defining the interconnectivity of the medial prefrontal cortex and ventral midbrain.

Hui M, Beier K Front Mol Neurosci. 2022; 15:971349.

PMID: 35935333 PMC: 9354837. DOI: 10.3389/fnmol.2022.971349.

Opposing Cholinergic and Serotonergic Modulation of Layer 6 in Prefrontal Cortex.

Sparks D, Tian M, Sargin D, Venkatesan S, Intson K, Lambe E Front Neural Circuits. 2018; 11:107.

PMID: 29354034 PMC: 5758509. DOI: 10.3389/fncir.2017.00107.

Serotonergic Suppression of Mouse Prefrontal Circuits Implicated in Task Attention.

Tian M, Schmidt E, Lambe E eNeuro. 2016; 3(5).

PMID: 27844060 PMC: 5099606. DOI: 10.1523/ENEURO.0269-16.2016.

References

Rabiner E, Bhagwagar Z, Gunn R, Cowen P, Grasby P . Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?. Neuropsychopharmacology. 2004; 29(9):1688-98. DOI: 10.1038/sj.npp.1300472. View

Carli M, Samanin R . The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Psychopharmacology (Berl). 2000; 149(3):259-68. DOI: 10.1007/s002139900368. View

Rabiner E, Bhagwagar Z, Gunn R, Sargent P, Bench C, Cowen P . Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Am J Psychiatry. 2001; 158(12):2080-2. DOI: 10.1176/appi.ajp.158.12.2080. View

Aronson S, Delgado P . Escitalopram. Drugs Today (Barc). 2004; 40(2):121-31. DOI: 10.1358/dot.2004.40.2.799424. View

Liechti M, Saur M, Gamma A, Hell D, Vollenweider F . Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology. 2000; 23(4):396-404. DOI: 10.1016/S0893-133X(00)00126-3. View

Harmer C, McTavish S, Clark L, Goodwin G, Cowen P . Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl). 2001; 154(1):105-11. DOI: 10.1007/s002130000613. View

OHanlon J, Robbe H, Vermeeren A, van Leeuwen C, Danjou P . Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol. 1998; 18(3):212-21. DOI: 10.1097/00004714-199806000-00006. View

Spoont M . Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull. 1992; 112(2):330-50. DOI: 10.1037/0033-2909.112.2.330. View

Lucas G, Spampinato U . Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J Neurochem. 2000; 74(2):693-701. DOI: 10.1046/j.1471-4159.2000.740693.x. View

10.

Rabiner E, Gunn R, Wilkins M, Sargent P, Mocaer E, Sedman E . Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635. Nucl Med Biol. 2000; 27(5):509-13. DOI: 10.1016/s0969-8051(00)00120-7. View

11.

Ramaekers J, Muntjewerff N, OHanlon J . A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol. 1995; 39(4):397-404. PMC: 1365127. DOI: 10.1111/j.1365-2125.1995.tb04468.x. View

12.

SCHMITT J, Jorissen B, Sobczak S, van Boxtel M, Hogervorst E, Deutz N . Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J Psychopharmacol. 2000; 14(1):21-9. DOI: 10.1177/026988110001400102. View

13.

Nicholson A, Pascoe P . Dopaminergic transmission and the sleep-wakefulness continuum in man. Neuropharmacology. 1990; 29(4):411-7. DOI: 10.1016/0028-3908(90)90101-v. View

14.

de Wit H, Crean J, Richards J . Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci. 2000; 114(4):830-7. DOI: 10.1037//0735-7044.114.4.830. View

15.

Jex H, McDonnell J, Phatak A . A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR. 1966; :1-105. View

16.

Harrison B, Olver J, Norman T, Burrows G, Wesnes K, Nathan P . Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. J Psychopharmacol. 2004; 18(1):32-40. DOI: 10.1177/0269881104040225. View

17.

Esposito E . Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr Drug Targets. 2006; 7(2):177-85. DOI: 10.2174/138945006775515455. View

18.

Blokland A, Sik A, Lieben C . Evaluation of DOI, 8-OH-DPAT, eticlopride and amphetamine on impulsive responding in a reaction time task in rats. Behav Pharmacol. 2005; 16(2):93-100. DOI: 10.1097/00008877-200503000-00004. View

19.

Matrenza C, Hughes J, Kemp A, Wesnes K, Harrison B, Nathan P . Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory. J Psychopharmacol. 2004; 18(1):21-31. DOI: 10.1177/0269881104040215. View

20.

PRIBRAM K, McGuinness D . Arousal, activation, and effort in the control of attention. Psychol Rev. 1975; 82(2):116-49. DOI: 10.1037/h0076780. View